HuMax-CD4: Began Phase II trials

Genmab A/S (CSE:GEN; NMarkt:GE9D), Brondby, Denmark Product: HuMax-CD4 Business: Autoimmune/Inflammation Therapeutic category: Antibody, Immune suppression Target: CD4 Description: Human antibody aga...